Activity of quinupristin–dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy

This publication has 19 references indexed in Scilit:

• Antibiotic Susceptibility and Serotype Distribution ofStreptococcus pneumoniaeCausing Meningitis in Italy, 1997–1999
  Clinical Infectious Diseases, 2000
• The Emergence ofStreptococcus pneumoniaeResistant to Macrolide Antimicrobial Agents: A 6‐Year Population‐Based Assessment
  The Journal of Infectious Diseases, 2000
• Comparative In Vitro Activities of Linezolid, Quinupristin-Dalfopristin, Moxifloxacin, and Trovafloxacin against Erythromycin-Susceptible and -Resistant Streptococci
  Antimicrobial Agents and Chemotherapy, 2000
• Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants
  Antimicrobial Agents and Chemotherapy, 1999
• Prevalence of Macrolide Resistance Mechanisms in Streptococcus pneumoniae Isolates from a Multicenter Antibiotic Resistance Surveillance Study Conducted in the United States in 1994-1995
  Clinical Infectious Diseases, 1999
• Patterns of Macrolide Resistance Determinants among Community-Acquired Streptococcus pneumoniae Isolates over a 5-Year Period of Decreased Macrolide Susceptibility Rates
  Antimicrobial Agents and Chemotherapy, 1999
• Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy
  Journal of Antimicrobial Chemotherapy, 1999
• New faces of an old pathogen: emergence and spread of multidrug-resistant Streptococcus pneumoniae
  The American Journal of Medicine, 1999
• Streptogramins: an answer to antibiotic resistance in gram-positive bacteria
  The Lancet, 1998
• Antipneumococcal Activities of a Ketolide (HMR 3647), a Streptogramin (Quinupristin-Dalfopristin), a Macrolide (Erythromycin), and a Lincosamide (Clindamycin)
  Antimicrobial Agents and Chemotherapy, 1998